Sign up to access all valuation multiples
Sawai Group Holdings Co Ltd is engaged in providing management support or guidance to domestic and foreign companies engaged in businesses related to medical and healthcare services, such as the manufacture and sale of pharmaceutical products and medical equipment, as well as various businesses incidental or related to the same.
2021
3.1K+
LTM Revenue $1.3B
LTM EBITDA $259M
$2.0B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Sawai Group Holdings has a last 12-month revenue (LTM) of $1.3B and a last 12-month EBITDA of $259M.
In the most recent fiscal year, Sawai Group Holdings achieved revenue of $1.3B and an EBITDA of $244M.
Sawai Group Holdings expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Sawai Group Holdings valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.3B | XXX | $1.3B | XXX | XXX | XXX |
| Gross Profit | $403M | XXX | $380M | XXX | XXX | XXX |
| Gross Margin | 31% | XXX | 30% | XXX | XXX | XXX |
| EBITDA | $259M | XXX | $244M | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | 19% | XXX | XXX | XXX |
| EBIT | $155M | XXX | $140M | XXX | XXX | XXX |
| EBIT Margin | 12% | XXX | 11% | XXX | XXX | XXX |
| Net Profit | $140M | XXX | $155M | XXX | XXX | XXX |
| Net Margin | 11% | XXX | 12% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $354M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of August 29, 2025, Sawai Group Holdings's stock price is JPY 1874 (or $13).
Sawai Group Holdings has current market cap of JPY 216B (or $1.5B), and EV of JPY 292B (or $2.0B).
See Sawai Group Holdings trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.0B | $1.5B | XXX | XXX | XXX | XXX | $1.15 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of August 29, 2025, Sawai Group Holdings has market cap of $1.5B and EV of $2.0B.
Sawai Group Holdings's trades at 1.6x EV/Revenue multiple, and 8.0x EV/EBITDA.
Equity research analysts estimate Sawai Group Holdings's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Sawai Group Holdings has a P/E ratio of 10.4x.
See valuation multiples for Sawai Group Holdings and 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.5B | XXX | $1.5B | XXX | XXX | XXX |
| EV (current) | $2.0B | XXX | $2.0B | XXX | XXX | XXX |
| EV/Revenue | 1.5x | XXX | 1.6x | XXX | XXX | XXX |
| EV/EBITDA | 7.6x | XXX | 8.0x | XXX | XXX | XXX |
| EV/EBIT | 12.7x | XXX | 14.4x | XXX | XXX | XXX |
| EV/Gross Profit | 4.9x | XXX | n/a | XXX | XXX | XXX |
| P/E | 10.4x | XXX | 10.5x | XXX | XXX | XXX |
| EV/FCF | 14.9x | XXX | -2387.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialSawai Group Holdings's last 12 month revenue growth is 7%
Sawai Group Holdings's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.
Sawai Group Holdings's rule of 40 is 27% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Sawai Group Holdings's rule of X is 37% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Sawai Group Holdings and other 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 7% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | 20% | XXX | XXX | XXX |
| EBITDA Growth | 16% | XXX | 12% | XXX | XXX | XXX |
| Rule of 40 | 27% | XXX | 27% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 37% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 7% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 19% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Armata Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Sawai Group Holdings acquired XXX companies to date.
Last acquisition by Sawai Group Holdings was XXXXXXXX, XXXXX XXXXX XXXXXX . Sawai Group Holdings acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was Sawai Group Holdings founded? | Sawai Group Holdings was founded in 2021. |
| Where is Sawai Group Holdings headquartered? | Sawai Group Holdings is headquartered in Japan. |
| How many employees does Sawai Group Holdings have? | As of today, Sawai Group Holdings has 3.1K+ employees. |
| Who is the CEO of Sawai Group Holdings? | Sawai Group Holdings's CEO is Mr. Mitsuo Sawai. |
| Is Sawai Group Holdings publicy listed? | Yes, Sawai Group Holdings is a public company listed on TKS. |
| What is the stock symbol of Sawai Group Holdings? | Sawai Group Holdings trades under 4887 ticker. |
| When did Sawai Group Holdings go public? | Sawai Group Holdings went public in 2021. |
| Who are competitors of Sawai Group Holdings? | Similar companies to Sawai Group Holdings include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics. |
| What is the current market cap of Sawai Group Holdings? | Sawai Group Holdings's current market cap is $1.5B |
| What is the current revenue of Sawai Group Holdings? | Sawai Group Holdings's last 12 months revenue is $1.3B. |
| What is the current revenue growth of Sawai Group Holdings? | Sawai Group Holdings revenue growth (NTM/LTM) is 7%. |
| What is the current EV/Revenue multiple of Sawai Group Holdings? | Current revenue multiple of Sawai Group Holdings is 1.5x. |
| Is Sawai Group Holdings profitable? | Yes, Sawai Group Holdings is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Sawai Group Holdings? | Sawai Group Holdings's last 12 months EBITDA is $259M. |
| What is Sawai Group Holdings's EBITDA margin? | Sawai Group Holdings's last 12 months EBITDA margin is 20%. |
| What is the current EV/EBITDA multiple of Sawai Group Holdings? | Current EBITDA multiple of Sawai Group Holdings is 7.6x. |
| What is the current FCF of Sawai Group Holdings? | Sawai Group Holdings's last 12 months FCF is $132M. |
| What is Sawai Group Holdings's FCF margin? | Sawai Group Holdings's last 12 months FCF margin is 10%. |
| What is the current EV/FCF multiple of Sawai Group Holdings? | Current FCF multiple of Sawai Group Holdings is 14.9x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
